Neutropenia and Cancer Infections
Neutropenia and Cancer Infections is a research topic within Oncology. Science Explorer counts 20k research works in it since 1950. 11.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management of febrile neutropenia in cancer patients, particularly those with hematological malignancies receiving chemotherapy. It includes clinical practice guidelines, updates on antimicrobial agents, use of granulocyte colony-stimulating factor, risk assessment tools, prophylactic strategies, and the impact of febrile neutropenia on morbidity and mortality.
- Febrile Neutropenia
- Antimicrobial Agents
- Neutropenic Patients
- Cancer
- Clinical Practice Guideline
- Granulocyte Colony-Stimulating Factor
- Infections
- Chemotherapy
- Hematological Malignancies
- Prophylaxis
- Research works
- 20k fractional, since 1950
- In the world top 10%
- 2.3k per year above
- Top-10% rate
- 11.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +31% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Neutropenia and Cancer Infections research?
By volume, the United States and China publish the most (875 and 411 works in 2022–2025).
By volume, 2022–2025
- 1 United States 875 works
- 2 China 411 works
- 3 Japan 180 works
- 4 India 176 works
- 5 Brazil 122 works
- 6 France 116 works
- 7 Germany 111 works
- 8 Italy 101 works
- 9 United Kingdom 95 works
- 10 Spain 94 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Neutropenia and Cancer Infections research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Neutropenia and Cancer Infections research, followed by All India Institute of Medical Sciences and Memorial Sloan Kettering Cancer Center.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 37 works
- 2 All India Institute of Medical SciencesIndia 16 works
- 3 Memorial Sloan Kettering Cancer CenterUnited States 15 works
- 4 University of North Carolina at Chapel HillUnited States 13 works
- 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
- 6 University of WashingtonUnited States 10 works
- 7 Cleveland ClinicUnited States 10 works
- 8 Fred Hutch Cancer CenterUnited States 10 works
- 9 Moffitt Cancer CenterUnited States 10 works
- 10 St. Jude Children's Research HospitalUnited States 10 works
Who are the leading researchers in Neutropenia and Cancer Infections?
The most-cited researchers publishing on Neutropenia and Cancer Infections include Peter C Gøtzsche, Karla Soares‐Weiser and Hagop M. Kantarjian.
- 1 Peter C Gøtzsche Denmark 6.7k citations
- 2 Karla Soares‐Weiser United Kingdom 4.9k citations
- 3 Hagop M. Kantarjian United States 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Neutropenia and Cancer Infections research done?
The largest centres of Neutropenia and Cancer Infections research in 2022–2025 are Houston (United States), Beijing (China), New York (United States) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Houston and Seattle.
Largest cities, 2022–2025
Where it is the local speciality
- HoustonUS · 56.4 works7.1×
- SeattleUS · 26.2 works4.3×
Location quotient: how much more of its research is in Neutropenia and Cancer Infections than the world average.
Where is the best place to study Neutropenia and Cancer Infections?
Among universities, judged by research, Peking University, Chinese Academy of Medical Sciences & Peking Union Medical College and University of North Carolina at Chapel Hill score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Peking UniversityChina | 38.0 | 26.5% | 1.7× | 9 | +23.8% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 28.7 | 9.9% | 3.8× | 12 | +44.9% |
| 3 | University of North Carolina at Chapel HillUnited States | 28.5 | 4.9% | 2.4× | 13 | +133.1% |
| 4 | All India Institute of Medical SciencesIndia | 27.8 | 0.7% | 8.1× | 16 | +7.7% |
| 5 | University of WashingtonUnited States | 25.6 | 11.1% | 3.2× | 10 | +9.0% |
| 6 | Soochow UniversityChina | 21.4 | 2.0% | 3.2× | 8 | +118.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Neutropenia and Cancer Infections research growing?
Output in 2018–2022 was 31% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Neutropenia and Cancer Infections.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.